/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

David H. Vesole

Hackensack University Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

374

Papers

18.6K

Citations

63

h-index

158

i10-index

David H. Vesole is an academic researcher from Hackensack University Medical Center. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Hematopoietic Stem Cell Transplantation. The author has an h-index of 63, co-authored 318 publications.

ORCID: 0000-0001-7721-3870

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Hematopoietic Stem Cell Transplantation Cancer Treatment and Pharmacology Peptidase Inhibition and Analysis

Papers by this author

works

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

2003 · Bone Marrow Transplantation · 247 citations

https://doi.org/10.1038/sj.bmt.1704086

Linda J. Burns Daniel J. Weisdorf Todd E. DeFor David H. Vesole

Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

2009 · Biology of Blood and Marrow Transplantation · 64 citations

https://doi.org/10.1016/j.bbmt.2009.11.007

Parameswaran Hari Navneet S. Majhail Mei-Jie Zhang Anna Hassebroek

Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

2022 · Blood Cancer Journal · 39 citations

https://doi.org/10.1038/s41408-022-00624-6

Angela Dispenzieri Amrita Krishnan Bonnie K. Arendt Beth Blackwell

A Phase II Trial of Autologous Stem Cell Transplantation Followed by Mini-Allogeneic Stem Cell Transplantation for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97

2009 · Biology of Blood and Marrow Transplantation · 29 citations

https://doi.org/10.1016/j.bbmt.2008.10.030

David H. Vesole Lijun Zhang Neal Flomenberg Philip R. Greipp

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma

2016 · Biology of Blood and Marrow Transplantation · 22 citations

https://doi.org/10.1016/j.bbmt.2016.11.011

Robert F. Cornell Anita D’Souza Adetola A. Kassim Luciano J. Costa

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

2016 · Biology of Blood and Marrow Transplantation · 19 citations

https://doi.org/10.1016/j.bbmt.2016.10.010

Robert F. Cornell Veronika Bachanová Anita D’Souza Kwang Wooahn

Research topics

topics

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Hematopoietic Stem Cell Transplantation

Cancer Treatment and Pharmacology

Peptidase Inhibition and Analysis

Chat about Author

Papers

Chat

Click to start Chat